<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Association between <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development is exemplified by <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) where patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> uncontrolled <z:hpo ids='HP_0002583'>colitis</z:hpo> have a significantly increased risk of developing <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (CACC) </plain></SENT>
<SENT sid="1" pm="."><plain>CACC appears to progresses through the <z:mp ids='MP_0001845'>inflammation</z:mp>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence </plain></SENT>
<SENT sid="2" pm="."><plain>This highlights the need to identify targets and interventions that reduce <z:mp ids='MP_0001845'>inflammation</z:mp> and prevent development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in the context of IBD </plain></SENT>
<SENT sid="3" pm="."><plain>Using the <z:chebi fb="0" ids="34674">dextran sulfate</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> (DSS) mouse model of <z:hpo ids='HP_0100281'>chronic colitis</z:hpo> and CACC, we show that an important target of intervention in human disease would be the epithelial cell molecule MUC1 that is aberrantly expressed on inflamed colonocytes and promotes <z:mp ids='MP_0001845'>inflammation</z:mp> and progression to CACC </plain></SENT>
<SENT sid="4" pm="."><plain>We show that a MUC1 vaccine can ameliorate <z:hpo ids='HP_0100281'>chronic colitis</z:hpo> and prevent development of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in the colon and thus extend survival in human MUC1 transgenic mice </plain></SENT>
<SENT sid="5" pm="."><plain>This study supports the potential of prophylactic vaccines to target antigens that become aberrantly expressed in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> (e.g., IBD) and continue to be expressed on the associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (e.g., <z:hpo ids='HP_0003003'>colon cancer</z:hpo>), to prevent and/or treat both diseases </plain></SENT>
</text></document>